As a biotechnology company specializing in cell biology, AcceGen provides authenticated cellular models and comprehensive technical support to companies and research institutions worldwide across nine core research areas.
InCancer Research, our tumor cell lines and tumor cell line-derived exosome products support tumor microenvironment simulation and therapeutic drug discoveries, while our cancer stem cells facilitate tumor heterogeneity and differentiation mechanism determinations. For Metabolic and Cardiovascular Studies, primary and iPSC-derived cardiomyocytes, as well as immortalized cell lines are optimized for energy metabolism pathway investigations, accelerating drug toxicity evaluations through integrated high-throughput screening. In infection & Immunity research, pathogen-sensitive cell lines and customized immune cell models enableprecise simulation of virus-host interactions, and provide valuable tools to facilitate the development of new therapies against diseases like virus infection and cancer. In Genetic Disorders and Regenerative Research, our iPSCs/ESCs and CRISPR-based gene editing tools enable precise cellular reprogramming, targeted genetic modifications and tissue regeneration studies. For Neuroscience, our primary neural cell models and immortalized neural cell lines support scientists to study neurodegenerative disease mechanisms, test potential therapies, and gain insights into the complex cellular processes. In Respiratory Research, our primary alveolar epithelial and endothelial cells, bronchial smooth muscle cells, and alveolar macrophages serve as reliable models for airway inflammation and viral infection studies. For Dermatological Research, we provide tools like skin-derived primary cells and miRNA modulators to facilitate investigations into wound healing, skin barrier function, and infection-related skin disorders.
AcceGen offers end-to-end technical support—from cell models selection and gene editing to functional validation—empowering researchers to bridge the gap between basic research and clinical translation. All cellular products undergo rigorous quality control, including authenticating through STR profiling, viability testing, and contamination screening for bacteria, fungi, yeast, syphilis, mycoplasma, HIV, HBV and HCV to ensure the integrity and reliability.
With over 6 years of industry expertise, AcceGen has delivered cellular resources to more than 100 biopharmaceutical companies and academic institutes across over 40 countries. AcceGen is a reliable partner for life science research, offering scientific rigour and technical adaptability in disease mechanisms, screening drug targets and gene therapy optimization.
